Baxter International has formed an agreement to acquire two hemostat and sealant products from Mallinckrodt—Recothrom Thrombin topical (Recombinant), the first and only stand-alone recombinant thrombin, and Preveleak Surgical Sealant, which is used in vascular reconstruction. Baxter will pay approximately $153 million for both products. “Uncontrolled intraoperative bleeding can lead to a wide variety of clinical and economic complications for patients and hospitals. As a leading provider of a...